Concerns about escalating tensions with North Korea weighed the markets down to a lower open with the Dow dropping 62 points to 14,503. Nasdaq lost 7 points to 3196.
On the upside
Rising cases of H7N9 avian flu in China lifted shares of flu treatment maker BioCryst Pharmaceuticals (Nasdaq: BCRX).
Trina Solar (NYSE: TSL) expects to become profitable in the second half of the year.
On the downside
Merz Pharma withdrew its $22 per share cash offer to acquire Obagi Medical Products (Nasdaq: OMPI).
J. P. Morgan downgraded Johnson & Johnson (NYSE: JNJ) to a Neutral rating.
The Food and Drug Administration extended the Prescription Drug User Fee Act goal date for reviewing Delcath Systems' (Nasdaq: DCTH) Melblez Kit.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index slipped 3 points to 1549.